• Pressemeldinger
  • Børsmeldinger
  • Business Wire
  • GlobeNewswire by notified
news aktuell GmbH

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation7.12.2021 14:28:03 CET | news aktuell GmbH

Darmstadt, 7 December 2021 – R-Biopharm, an international specialist in clinical diagnostics, announces that the company’s RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825) has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”). R-Biopharm will now work to resume the sale of the product in the UK.
  • 1
  • 2
  • 3
  • 4
  • 5
  • Siste
  • >>